• Earlier this week, McEwen Inc. reported Q1 2026 results showing net income of US$33.4 million and revenue growth of very large versus a year earlier, reaffirmed its 2026 production guidance, and detailed progress on projects across North and South America.
• The company also advanced its long-term growth plan by activating a 50-50 joint venture on the New Pass gold property in Nevada, completing the Golden Lake Resources acquisition near its Gold Bar complex, and outlining a path to 250,000–300,000 gold-equivalent ounces of production by 2030.
• We’ll now examine how this return to quarterly profitability and clarified 2030 production ambitions could reshape McEwen’s existing investment narrative.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

McEwen Investment Narrative Recap

To own McEwen today, you need to believe it can turn its recent profitability into steady cash generation while executing multiple growth projects without major delays or cost surprises. Q1 2026’s US$33.4 million net income helps address concerns about ongoing operational underperformance, but it does not remove the execution and permitting risks around projects like Los Azules, Tartan, and the Nevada assets that still loom as the key swing factors.

The most relevant recent development here is McEwen’s reaffirmed plan to reach 250,000 to 300,000 gold equivalent ounces of annual production by 2030, supported by progress at Stock, Gold Bar, San José and the new Nevada initiatives. This gives clearer context for the New Pass joint venture and Golden Lake acquisition, tying them directly to the same volume and cost catalysts that need to come through for the current growth narrative to hold.

Yet behind the strong quarter, investors should also be aware of the risk that multi year permitting and project execution timelines in Nevada and Argentina could still...

McEwen's narrative projects $433.2 million revenue and $123.2 million earnings by 2029. This requires 29.9% yearly revenue growth and an earnings increase of about $88.8 million from $34.4 million today.

Uncover how McEwen's forecasts yield a $31.70 fair value, a 36% upside to its current price.

Exploring Other Perspectives

Before this earnings beat, the most cautious analysts already assumed revenue could reach about US$565 million and earnings about US$459 million by 2029, yet they still framed McEwen as high risk because that growth relied heavily on projects like Grey Fox and Tartan coming through. The Q1 news may eventually shift those expectations, but you should recognize how sharply views differ and consider how your own outlook lines up with these more pessimistic scenarios.

Explore 7 other fair value estimates on McEwen - why the stock might be a potential multi-bagger!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your McEwen research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free McEwen research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate McEwen's overall financial health at a glance.

Want Some Alternatives?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 33 companies in the world exploring or producing it. Find the list for free.
• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.